Detection	O
of	O
Enhancer	O
-	O
Associated	O
Rearrangements	O
Reveals	O
Mechanisms	O
of	O
Oncogene	O
Dysregulation	O
in	O
B	B-DISEASE
-	I-DISEASE
cell	I-DISEASE
Lymphoma	E-DISEASE
.	O


UNLABELLED	O
:	O
B	B-DISEASE
-	I-DISEASE
cell	I-DISEASE
lymphomas	E-DISEASE
frequently	O
contain	O
genomic	O
rearrangements	O
that	O
lead	O
to	O
oncogene	O
activation	O
by	O
heterologous	O
distal	O
regulatory	O
elements	O
.	O


We	O
used	O
a	O
novel	O
approach	O
called	O
"	O
pinpointing	O
enhancer	O
-	O
associated	O
rearrangements	O
by	O
chromatin	O
immunoprecipitation	O
,	O
"	O
or	O
PEAR	O
-	O
ChIP	O
,	O
to	O
simultaneously	O
map	O
enhancer	O
activity	O
and	O
proximal	O
rearrangements	O
in	O
lymphoma	O
cell	O
lines	O
and	O
patient	O
biopsies	O
.	O


This	O
method	O
detects	O
rearrangements	O
involving	O
known	O
cancer	S-DISEASE
genes	O
,	O
including	O
CCND1	O
,	O
BCL2	O
,	O
MYC	O
,	O
PDCD1LG2	O
,	O
NOTCH1	O
,	O
CIITA	O
,	O
and	O
SGK1	O
,	O
as	O
well	O
as	O
novel	O
enhancer	O
duplication	O
events	O
of	O
likely	O
oncogenic	O
significance	O
.	O


We	O
identify	O
lymphoma	S-DISEASE
subtype	O
-	O
specific	O
enhancers	O
in	O
the	O
MYC	O
locus	O
that	O
are	O
silenced	O
in	O
lymphomas	S-DISEASE
with	O
MYC	O
-	O
activating	O
rearrangements	O
and	O
are	O
associated	O
with	O
germline	O
polymorphisms	O
that	O
alter	O
lymphoma	S-DISEASE
risk	O
.	O


We	O
show	O
that	O
BCL6	O
-	O
locus	O
enhancers	O
are	O
acetylated	O
by	O
the	O
BCL6	O
-	O
activating	O
transcription	O
factor	O
MEF2B	O
,	O
and	O
can	O
undergo	O
genomic	O
duplication	O
,	O
or	O
target	O
the	O
MYC	O
promoter	O
for	O
activation	O
in	O
the	O
context	O
of	O
a	O
"	O
pseudo	O
-	O
double	O
-	O
hit	O
"	O
t	O
(	O
3	O
;	O
8	O
)	O
(	O
q27	O
;	O
q24	O
)	O
rearrangement	O
linking	O
the	O
BCL6	O
and	O
MYC	O
loci	O
.	O


Our	O
work	O
provides	O
novel	O
insights	O
regarding	O
enhancer	O
-	O
driven	O
oncogene	O
activation	O
in	O
lymphoma	S-DISEASE
.	O


SIGNIFICANCE	O
:	O
We	O
demonstrate	O
a	O
novel	O
approach	O
for	O
simultaneous	O
detection	O
of	O
genomic	O
rearrangements	O
and	O
enhancer	O
activity	O
in	O
tumor	S-DISEASE
biopsies	O
.	O


We	O
identify	O
novel	O
mechanisms	O
of	O
enhancer	O
-	O
driven	O
regulation	O
of	O
the	O
oncogenes	O
MYC	O
and	O
BCL6	O
,	O
and	O
show	O
that	O
the	O
BCL6	O
locus	O
can	O
serve	O
as	O
an	O
enhancer	O
donor	O
in	O
an	O
"	O
enhancer	O
hijacking	O
"	O
translocation	O
.	O
